BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 2294980)

  • 1. Plasma dexamethasone concentrations and the dexamethasone suppression test.
    Ritchie JC; Belkin BM; Krishnan KR; Nemeroff CB; Carroll BJ
    Biol Psychiatry; 1990 Jan; 27(2):159-73. PubMed ID: 2294980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lower limits of dexamethasone window in Chinese depressives.
    Shiah IS; Ko HC; Lu RB
    Biol Psychiatry; 1998 Oct; 44(7):648-55. PubMed ID: 9787892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results.
    O'Sullivan BT; Hunt GE; Johnson GF; Caterson ID
    Biol Psychiatry; 1989 Mar; 25(6):739-54. PubMed ID: 2923936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high plasma dexamethasone levels on DST sensitivity: dose-response study in depressed patients and controls.
    Hunt GE; O'Sullivan BT; Johnson GF; Caterson ID
    Psychiatry Res; 1991 Feb; 36(2):209-22. PubMed ID: 2017535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
    Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone kinetics in depressed patients before and after clinical response.
    Maguire KP; Tuckwell VM; Schweitzer I; Tiller JW; Davies BM
    Psychoneuroendocrinology; 1990; 15(2):113-23. PubMed ID: 2359809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.
    Holsboer F; Haack D; Gerken A; Vecsei P
    Biol Psychiatry; 1984 Mar; 19(3):281-91. PubMed ID: 6722226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of age on cortisol and plasma dexamethasone concentrations in depressed patients and controls.
    Hunt GE; Johnson GF; Caterson ID
    J Affect Disord; 1989; 17(1):21-32. PubMed ID: 2525575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The plasma dexamethasone variable in depression: test-retest studies and early biophase kinetics.
    Holsboer F; Wiedemann K; Gerken A; Boll E
    Psychiatry Res; 1986 Feb; 17(2):97-103. PubMed ID: 3961034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of serum dexamethasone concentrations in the dexamethasone suppression test.
    Carr V; Morris H; Gilliland J
    Biol Psychiatry; 1986 Jul; 21(8-9):735-43. PubMed ID: 3730458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients.
    Johnson GF; Hunt G; Kerr K; Caterson I
    Psychiatry Res; 1984 Dec; 13(4):305-13. PubMed ID: 6596587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary and adrenal hormone responsiveness to Synacthen in melancholic subjects versus subjects with minor depression.
    Maes M; Meltzer H; Cosyns P; Calabrese J; D'Hondt P; Blockx P; Vandervorst C; Raus J
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):624-9. PubMed ID: 8392386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma dexamethasone levels in children given the dexamethasone suppression test.
    Naylor MW; Greden JF; Alessi NE
    Biol Psychiatry; 1990 Mar; 27(6):592-600. PubMed ID: 2322618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers.
    Schweitzer I; Tuckwell VM; Maguire KP; Tiller JW; Harrison LC; Davies BM
    Psychoneuroendocrinology; 1991; 16(5):375-82. PubMed ID: 1805291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified dexamethasone suppression test for endogenous depression.
    Poland RE; Rubin RT; Lane LA; Martin DJ; Rose DE; Lesser IM
    Psychiatry Res; 1985 Aug; 15(4):293-9. PubMed ID: 3865246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influences of dexamethasone levels on the predictive value of the DST for unipolar major depression and the relationships between post-dexamethasone cortisol and ACTH levels.
    Maes M; Minner B; Suy E
    J Affect Disord; 1989; 17(1):39-46. PubMed ID: 2544636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dexamethasone suppression test: importance of dexamethasone concentrations.
    Maguire KP; Schweitzer I; Biddle N; Bridge S; Tiller JW
    Biol Psychiatry; 1987 Aug; 22(8):957-67. PubMed ID: 3607137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects.
    O'Sullivan BT; Cutler DJ; Hunt GE; Walters C; Johnson GF; Caterson ID
    Biol Psychiatry; 1997 Mar; 41(5):574-84. PubMed ID: 9046990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of plasma cortisol and corticosterone in the dexamethasone suppression test for melancholia.
    Wilens TE; Ritchie JC; Carroll BJ
    Psychoneuroendocrinology; 1984; 9(1):45-55. PubMed ID: 6739664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An augmented escape of androstenedione from suppression by dexamethasone in melancholia: relationships to intact ACTH and cortisol nonsuppression.
    Maes M; Van Gastel A; Blockx P; Martin M; Cosyns P; Scharpé S; Desnyder R
    J Affect Disord; 1995 Aug; 34(4):291-300. PubMed ID: 8550955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.